GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Gate AG (XTER:BIG1) » Definitions » Institutional Ownership

Bio-Gate AG (XTER:BIG1) Institutional Ownership : 0.06% (As of Jun. 19, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Bio-Gate AG Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bio-Gate AG's institutional ownership is 0.06%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bio-Gate AG's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bio-Gate AG's Float Percentage Of Total Shares Outstanding is 0.00%.


Bio-Gate AG Institutional Ownership Historical Data

The historical data trend for Bio-Gate AG's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Gate AG Institutional Ownership Chart

Bio-Gate AG Historical Data

The historical data trend for Bio-Gate AG can be seen below:

2011-02-28 2021-03-31 2021-04-30 2021-05-31 2021-06-30 2021-07-31 2021-08-31 2021-09-30 2021-10-31 2021-11-30
Institutional Ownership 0.02 0.17 0.17 0.17 0.15 0.15 0.15 0.06 0.06 0.06

Bio-Gate AG Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Bio-Gate AG (XTER:BIG1) Business Description

Traded in Other Exchanges
Address
Neumeyerstraße 28-34, Nürnberg, DEU
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.
Executives
Karl Richter Supervisory Board

Bio-Gate AG (XTER:BIG1) Headlines

No Headlines